Nature Search

Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function

Zhenzi Cai
Corinne Capoulade
Salem Chouaib
Research04 Dec 1997
Oncogene

Volume: 15, P: 2817-2826
Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb

Maya Ameyar
Vladimir Shatrov
Salem Chouaib
Research23 Sept 1999
Oncogene

Volume: 18, P: 5464-5472
Erratum: Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Dalil Hannani
Marie Vétizou
Laurence Zitvogel
Amendments and Corrections03 Mar 2015
Cell Research

Volume: 25, P: 399-400
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours

Tumours can escape CD8 T-cell immunity by down-regulating antigen presentation machinery components, such as TAP. Here the authors describe tumour antigenic peptides processed by TAP-independent and -dependent pathways and show in mouse models that these peptides can be exploited to induce antitumor T-cell activity when TAP expression is downregulated.

Aurélie Durgeau
Yasemin Virk
Fathia Mami-Chouaib
ResearchOpen Access30 Nov 2018
Nature Communications

Volume: 9, P: 1-14
Regulation of major histocompatibility complex class I expression by NF-κB-related proteins in breast cancer cells

Emmanuel Dejardin
Valérie Deregowski
Vincent Bours
Research01 Jul 1998
Oncogene

Volume: 16, P: 3299-3307
Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria

Maya Ameyar-Zazoua
Nathanaël Larochette
Salem Chouaib
Research12 Mar 2002
Cancer Gene Therapy

Volume: 9, P: 219-227
Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity

Sebastian A Lewandowski
Jerome Thiery
Salem Chouaib
Research02 May 2005
Oncogene

Volume: 24, P: 4789-4798
Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma

Guillaume Dorothée
Hamid Echchakir
Fathia Mami-Chouaib
Research16 Oct 2003
Oncogene

Volume: 22, P: 7192-7198
Altered natural killer cell differentiation in CD34⁺ progenitors from Chronic Myeloid Leukemia patients

Géraldine Carayol
Julien Giron-Michel
Anne Caignard
Research31 May 2000
Oncogene

Volume: 19, P: 2758-2766
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression

I Akalay
T Z Tan
S Chouaib
Research16 Jun 2014
Oncogene

Volume: 34, P: 2261-2271
Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma

Jeanne Menez
Béatrice Le Maux Chansac
Fathia Mami-Chouaib
Research29 Mar 2004
Oncogene

Volume: 23, P: 2630-2639
Hypoxia differently modulates the release of mitochondrial and nuclear DNA

Amaelle Otandault
Jean-Daniel Abraham
Alain R. Thierry
ResearchOpen Access13 Jan 2020
British Journal of Cancer

Volume: 122, P: 715-725
Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells

Transcription factor STAT3 constitutively activated in cancer promotes tumor progression. The authors detected activated STAT3 in human metastatic melanoma cells and identified new STAT3 targets. STAT3 regulates a discrete set of genes in melanoma cells and its knockdown impairs cell migration and invasion via regulation of its transcriptional target SERPINA3.

Dorota W. Kulesza
Kavita Ramji
Bozena Kaminska
Research05 Jul 2019
Laboratory Investigation

Volume: 99, P: 1607-1621
The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy

Marie Chollat-Namy
Thouraya Ben Safta-Saadoun
Jerome Thiery
ResearchOpen Access20 Sept 2019
Cell Death & Disease

Volume: 10, P: 1-20
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

Vinoth-Kumar Lakshmanan
Shlok Jindal
Salem Chouaib
Reviews08 Feb 2021
Cancer Gene Therapy

Volume: 28, P: 911-923
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

Bassam Abdulkarim
Siham Sabri
Jean Bourhis
Research16 Apr 2002
Oncogene

Volume: 21, P: 2334-2346
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

Audrey Lequeux
Muhammad Zaeem Noman
Bassam Janji
ResearchOpen Access21 Jun 2021
Oncogene

Volume: 40, P: 4725-4735
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Dalil Hannani
Marie Vétizou
Laurence Zitvogel
Research13 Jan 2015
Cell Research

Volume: 25, P: 208-224
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

S Chouaib
M Z Noman
M A Curran
Reviews27 Jun 2016
Oncogene

Volume: 36, P: 439-445

Search

Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function

Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb

Erratum: Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours

Regulation of major histocompatibility complex class I expression by NF-κB-related proteins in breast cancer cells

Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria

Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity

Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma

Altered natural killer cell differentiation in CD34⁺ progenitors from Chronic Myeloid Leukemia patients

Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression

Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma

Hypoxia differently modulates the release of mitochondrial and nuclear DNA

Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells

The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy

Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

Search

Quick links

Search

Filter By:

Search

Quick links